Vogt-Koyanagi-Harada Disease
Ocul Immunol Inflamm
.
2024 May;32(4):363-366.
doi: 10.1080/09273948.2024.2331401.
Epub 2024 Apr 24.
Authors
Ilknur Tugal-Tutkun
1
2
,
Derrick P Smit
3
,
Ahmed M Abu El-Asrar
4
5
,
Carl P Herbort Jr
6
,
Jennifer E Thorne
7
8
Affiliations
1
Eye Protection Foundation Bayrampasa Eye Hospital, Istanbul, Turkey.
2
The Department of Ophthalmology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.
3
The Division of Ophthalmology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
4
Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
5
Dr. Nasser Al-Rashid Research Chair in Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
6
Inflammatory and Retinal Eye Diseases, Centre for Ophthalmic Specialised Care, Lausanne, Switzerland.
7
The Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
8
The Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
PMID:
38657222
DOI:
10.1080/09273948.2024.2331401
No abstract available
Publication types
Editorial
MeSH terms
Glucocorticoids / therapeutic use
Humans
Uveomeningoencephalitic Syndrome* / diagnosis
Uveomeningoencephalitic Syndrome* / drug therapy
Substances
Glucocorticoids